Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participant is at least two (2) years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial tests a home-use nasal swab test for COVID-19, Flu A&B. Subjects self-collect and interpret results to detect viral respiratory infection.
Who is the study for?
This trial is for people suspected of having a viral respiratory infection by a healthcare professional, within seven days of symptom onset, and experiencing symptoms like fever, cough, or loss of taste/smell. It's open to individuals aged two years and above. Those who've had certain flu treatments or vaccines recently, nasal procedures on the day of enrollment, COVID-19 treatment in the last 45 days, or are in another drug study can't join.Check my eligibility
What is being tested?
The Panbio™ COVID-19/Flu A&B Panel Self Test is being evaluated. Participants will self-collect nasal swabs and use this home test kit to check for qualitative detection of COVID-19 and Influenza A & B antigens.See study design
What are the potential side effects?
Since this trial involves a diagnostic test rather than medication or vaccine administration, typical side effects associated with drugs are not expected. However, discomfort from nasal swabbing may occur.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am at least 2 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Sensitivity and specificity of the Panbio™ COVID-19/Flu A&B Rapid Panel device
Trial Design
1Treatment groups
Experimental Treatment
Group I: Self-Testing GroupExperimental Treatment1 Intervention
Lay users (self-tester or caregiver) will be provided with a Panbio™ COVID-19/Flu A&B Rapid Panel Self-Test kit. Each lay user will collect one mid-turbinate nasal swab from both nostrils, perform and interpret the Panbio™ COVID-19/Flu A&B Rapid Panel Self-Test. All procedures for testing and result interpretation, including sample collection and extraction will be conducted by the lay user following the Instructions for Use provided in the kit. Participants will be asked to document their result interpretation and will pass the test to site staff, who will document their interpretation of the result. In addition, a second swab will be collected by study staff and eluted in Viral Transport Medium (VTM).
Find a Location
Who is running the clinical trial?
Abbott Rapid DxLead Sponsor
6 Previous Clinical Trials
11,278 Total Patients Enrolled
4 Trials studying COVID-19
3,155 Patients Enrolled for COVID-19
Share this study with friends
Copy Link
Messenger